United States
Germany
Japan
United Kingdom
China
Antibodies
p53 (TP53) sheep polyclonal antibody, Purified
| Applications | IHC, IP, WB |
| Reactivities | Human, Mouse, Rat |
sheep polyclonal antibody, Protein G purified
| Applications | ELISA, IF, IHC |
| Reactivities | Human, Mouse, Rat |
Histone H3 sheep polyclonal antibody, Purified
| Applications | IF, IHC, IP, WB |
| Reactivities | Bovine, Human |
Factor VIII Sheep Polyclonal Antibody
| Applications | IHC |
| Reactivities | Human |
Von Willebrand Factor (VWF) sheep polyclonal antibody, Purified
| Applications | ELISA, FC, ID, IF, IHC |
| Reactivities | Human |
Factor IX (F9) sheep polyclonal antibody, Aff - Purified
| Applications | ELISA, IHC, Neutralize |
| Reactivities | Human |
Psoriasin (S100A7) sheep polyclonal antibody, Purified
| Applications | IHC, IP, WB |
| Reactivities | Human |
PF4 sheep polyclonal antibody, Purified
| Applications | ELISA, IHC |
| Reactivities | Human |
Von Willebrand Factor (VWF) sheep polyclonal antibody, Purified
| Applications | ELISA, FC, ID, IF, IHC |
| Reactivities | Human |
Human IgA (Secretory component, free and bound) sheep polyclonal antibody, HRP
| Applications | This immunoconjugate is not pre-diluted. The optimum working dilution of each conjugate should be established by titration before being used. Excess labelled antibody must be avoided because it may cause high unspecific background staining and interfere with the specific signal. |
| Reactivities | Human |
| Conjugation | HRP |
TA355211 is a possible alternative to AP21476HR-N.
Factor VII (F7) sheep polyclonal antibody, Ig Fraction
| Applications | ELISA, IHC |
| Reactivities | Human |
活动过滤器
优化搜索结果
Target Symbol
Conjugates
Assay Types
Families
Pathways
- Complement and coagulation cascades (3)
- Oocyte meiosis (3)
- Wnt signaling pathway (3)
- Long-term depression (2)
- TGF-beta signaling pathway (2)
- Tight junction (2)
- Alzheimer's disease (1)
- Amyotrophic lateral sclerosis (ALS) (1)
- Apoptosis (1)
- Axon guidance (1)
- B cell receptor signaling pathway (1)
- Calcium signaling pathway (1)
- Chemokine signaling pathway (1)
- Cytokine-cytokine receptor interaction (1)
- Long-term potentiation (1)
- MAPK signaling pathway (1)
- Natural killer cell mediated cytotoxicity (1)
- T cell receptor signaling pathway (1)
- VEGF signaling pathway (1)
